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Abstract. After microinjection of antibodies against RNA 
polymerase I into the nuclei of cultured rat kangaroo (PtKz) 
and rat (RVF-SMC) cells alterations in nucleolar structure 
and composition were observed . These were detected by 
electron microscopy and double-label immunofluorescence 
microscopy using antibodies to proteins representative of 
the three major components of the nucleolus. The microin-
jected antibodies produced a progressive loss of the material 
of the dense fibrillar component (DFC) from the nucleoli 
which, at 4 h after injection, were transformed into bodies 
with purely granular component (GC) structure with at-
tached fibrillar centers (FCs). Concomitantly, numerous ex-
tranucleolar aggregates appeared in the nucleoplasm which 
morphologically resembled fragments of the DFC and con-
tained a protein (fibrillarin) diagnostic for this nucleolar 
structure. These observations indicate that the topological 
distribution of the material constituting the DFC can be 
experimentally influenced in interphase cells, apparently by 
modulating the transcriptional activity of the rRNA genes. 
These effects are different from nucleolar lesions induced 
by inhibitory drugs such as actinomycin D-dependent "nuc-
leolar segregation". The structural alterations induced by 
antibodies to RNA polymerase I resemble, however, the 
initial events of nucleolar disintegration during mitotic pro-
phase. 
Introduction 
The initial processes of ribosome biogenesis, i.e. synthesis 
and processing of precursors to cytoplasmic rRNA mole-
cules (pre-rRNAs) and their assembly with specific proteins, 
take place in the nucleolus (for reviews see Smetana and 
Busch 1974; Goessens 1984; Hadjiolov 1985). Various 
stages of the complex biochemical pathway have been local-
ized to specific subnucleolar compartments. By electron mi-
croscopy, three nucleolar components can be generally dis-
tinguished: the fibrillar center(s) (FC), the dense fibrillar 
component (DFC) which surrounds the FCs, and the gran-
ular component (GC) which usually constitutes the main 
body of the nucleolus (Goessens 1984). Based on autoradio-
graphic and biochemical studies primary steps of pre-ribo-
Abbreviations,' FC Fibrillar center; DFC dense fibrillar component; 
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some formation have been assigned to the DFC whereas 
subsequent maturation stages occur in the GC (Hadjiolov 
1985). The intranucleolar location of the transcription ally 
active rRNA genes is still a matter of debate. An immuno-
cytochemical approach has located RNA polymerase I in 
the FC, indicating that transcription of rDNA occurs within 
this nucleolar component (Scheer and Rose 1984; Reimer 
et al. 1987 a, b; Scheer and Raska 1987). In contrast, it 
has been suggested from earlier studies based on the distri-
bution of short-term labeled RNA that transcription takes 
place in - or at the border of - the DFC (for references 
see Goessens 1984; Hadjiolov 1985). 
One possible approach to the study of the functional 
organization of the nucleolus and the roles of the various 
nucleolar components in ribosome formation is the use of 
drugs that interfere with certain steps of ribosome biogene-
sis. Most of these inhibitors cause extensive alterations of 
the nucleolar architecture (for reviews see Busch and Sme-
tana 1970; Bernhard 1971; Simard et al. 1974; Hadjiolov 
1985). However, the interpretation of such structural rear-
rangements in relation to the molecular mechanism of drug 
action is often hindered due to the fact that inhibitors are 
not specific for the ribosome pathway but may also interfere 
with the synthesis and processing of other RNA classes. 
In addition, side effects of a given drug on other cellular 
metabolic pathways might occur which makes a correlation 
of the observed structural changes with certain molecular 
processes even more difficult. 
The group of inhibitors which interfere with the synthe-
sis of RNA molecules, including pre-rRNA, by DNA bind-
ing induce a characteristic redistribution of the nucleolar 
components, called "nucleolar segregation" (Busch and 
Smetana 1970; Bernhard 1971 ; Simard et al. 1974; Daskal 
1979; Goessens 1984). Actinomycin D (AMD), a DNA-
intercalating drug, is the most widely used member of this 
group. However, in interpretations of the changes of nuc-
leolar structure induced by treatment with AMD it has 
to be kept in mind that AMD inhibits preferentially but 
not exclusively the transcription of the rRNA genes (Perry 
1966). Hence, effects on other genes may also contribute 
to any phenomena observed. Furthermore, numerous re-
ports have shown that AMD might also affect the nucleocy-
toplasmic translocation of ribosomes, the stability of 
mRNA in the cytoplasm, and the translational machinery 
(for references see Eckert et al. 1975; Kostura and Craig 
1986). In this context it is also noteworthy that drugs known 
to inhibit pre-rRNA synthesis by different molecular mech-
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anisms may also have different effects on nucleolar struc-
ture (see Simard et aL 1974; Hadjiolov 1985). For example, 
while AMD induces extensive segregation of the nucleolar 
components, galactosamine D, which depletes the intracel-
lular UTP pool, leads to a loss of the GC of nucleoli in 
rat hepatocytes (e.g. Hadjiolov 1985; Hadjiolova et aL 
1986). 
Recent experiments have shown that pre-rRNA synthe-
sis can be selectively affected by introducing antibodies to 
RNA polymerase I, i.e. the enzyme responsible for rDNA 
transcription, into living cells (Mercer et aL 1984; Schlege1 
et aL 1985; Reimer et aL 1987a). These findings prompted 
us to study the effects of microinjected antibodies to RNA 
polymerase I on the organization and assembly of nucleolar 
components. Recently we have shown that cells microin-
jected with antibodies to RNA polymerase I during mitosis 
proceed through division and form daughter cells but are 
unable to reconstitute functional nucleoli (Benavente et aL 
1987). Using a series of antibodies reacting with other nuc-
leolar proteins we were able to follow, by immunofluores-
cence and electron microscopy, the behavior of the three 
major nucleolar components during these stages of experi-
mentally repressed nucleologenesis. In the present study we 
report that antibodies to RNA polymerase I and the reduc-
tion of rDNA transcription cause extensive structural chan-
ges and rearrangements of the nucleolar constituents which 
are, however, different from the segregation phenomenon 
induced by AMD treatment. 
Materials and methods 
Cells and microinjection. PtKz (rat kangaroo kidney epithe-
lial) and RVF-SMC cells (derived from vascular smooth 
muscle of rat vein) were grown on coverslips (for details 
see Franke et aL 1978, 1980). Microinjection into nuclei 
of interphase cells was performed as described (Benavente 
and Krohne 1986) with instrumentation as designed by An-
sorge (1982). 
Antibodies. The following antibodies were used for microin-
jection: (a) human S18 autoantibodies including antibodies 
directed against RNA polymerase I (Reimer et aL 1987 a). 
IgGs were purified by chromatography as described (Bena-
vente et aL 1987). (b) The IgG fraction of a rabbit serum 
containing antibodies to . RNA polymerase I (Rose et aL 
1981). (c) Monoclonal antibody Lo46F7 against Xenopus 
lamins Lm and L1v (Benavente et aL 1985; Benavente and 
Krohne 1985) used as IgG from ascites fluid (Benavente 
and Krohne 1986). All antibodies were dissolved in PBS 
(137 mM NaCl, 2.8 mM KCI, 7 mM Na2HP02 , 1.5 mM 
KH 2P04 , pH 7.4) and used for microinjection at concentra-
tions ranging from 3 to 20 mg/mL 
For immunofluorescence microscopy, the following an-
tibodies were used in addition: (a) monoclonal antibody 
72B9 against a protein of the DFC, related to the U3 ribon-
ucleoprotein (RNP) complex (Rei mer et aL 1987c). (b) Hu-
man Scl C auto antibodies recognizing a protein of the DFC 
identified as fibrillarin, that is probably related to the anti-
gen recognized by the monoclonal antibody 72B9 (Reimer 
etaL 1987c). (c) Monoclonal antibody RS1-105 against ri-
bosomal protein S1 (Hugle et aL 1985). 
Immunofluorescence microscopy. Double-label immunof-
luorescence microscopy of microinjected cells was per-
formed essentially as described (Benavente and Krohne 
1986; Benavente et aL 1987). Briefly, after methanol/ace-
tone fixation coverslips were incubated with fluorescein 
isothiocyanate (FITC)-conjugated antibodies (Dianova, 
Hamburg, FRG) directed against the microinjected anti-
body. Then the cells were incubated with antibody 72B9, 
Scl C or RSI-I05 followed by the appropriate secondary 
antibodies conjugated to Texas Red (Dianova, Hamburg, 
FRG). Cells grown in the presence of 0.08 to 0.2 Ilg/ml 
AMD (Serva, Heidelberg, FRG) were processed for double-
label immunofluorescence with RNA polymerase I anti-
bodies and monoclonal antibodies 72B9 or RS1-105. 
Electron microscopy. Coverslips with the microinjected cells 
were fixed with 2.5% glutaraldehyde followed by 1 % os-
mium tetroxide and processed for electron microscopy ac-
cording to standard procedures (see Benavente and Krohne 
1986; Benavente et aL 1987). For immunogold electron mi-
croscopy, cells were fixed in methanol (-20° C) for 10 min, 
dipped for a few seconds into cold acetone at - 20° C and 
then air-dried. Coverslips were then incubated with mono-
clonal antibody 72B9 for 15 min followed by incubation 
with secondary antibodies coupled to 5 nm gold particles 
(Janssen Life Sciences, Beerse, Belgium) diluted 1: 5 in PBS 
containing 0.2% bovine serum albumin for 1 h. After wash-
ing in PBS, the cells were fixed with 2.5% glutaraldehyde 
in 50 mM sodium cacodylate buffer (pH 7.2) for 15 min 
(4° C), postfixed with 1 % osmium tetroxide (15 min) at 
4° C, dehydrated in an ethanol series and embedded in 
Epon (for details see Benavente and Krohne 1986; Bena-
vente et aL 1987). Ultrathin sections were stained with ura-
nyl acetate and lead citrate. 
Results 
Following a 4 h exposure of PtK2 cells to low concentra-
tions of AMD (0.2 Ilg/ml), electron microscopy revealed 
the characteristic segregation of the three main nucleolar 
components (data not shown; cf. Ochs et aL 1985). In ul-
trathin sections, AMD-segregated nucleoli usually exhibited 
a stratified organization, i.e. the FC was located as a cap-
like structure at the nucleolar periphery, separated from 
the GC by an intervening layer ofDFC material (cf. Simard 
et aL 1974). These ultrastructural observations were con-
firmed by immunofluorescence microscopy of AMD-
treated PtK2 cells. Antibodies to RNA polymerase I, which 
in untreated cells decorate specifically the FCs of nucleoli 
(Scheer and Rose 1984; Reimer et aL 1987b), stained small, 
cap-like structures in the outer nucleolar zone (Fig. 1 a; for 
the immunofluorescence pattern of untreated PtK2 cells see 
Benavente et aL 1987). In contrast, monoclonal antibody 
72B9 reacting specifically with the DFC (Reimer et aL 
1987b) stained one or two roundish and much larger nuc-
leolar structures which could often be correlated with a 
region of the segregated nucleolus appearing light by phase 
contrast (Fig. la'; see also Schmidt-Zachmann et aL 1984; 
Hugle et aL 1985; Ochs et aL 1985). In the course of such 
AMD treatments, ribosomal protein SI, a marker for the 
GC (Hugle et aL 1985), progressively disappeared from the 
PtK2 cell nucleoli (Fig.2a', b'), indicative of an AMD-
induced clearance of precursor particles to the small ribo-
somal subunit from the nucleoli which in PtK2 cells oc-
curred much faster than in Xenopus cells of line A6 (Hugle 
et aL 1985). It should be emphasized that the AMD-induced 
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Fig. 1a--c. PtKz cells after exposure to actinomycin D (AMD) (a-a") and microinjection of RNA polymerase I (S18) antibodies into 
their nuclei (b-b", c--c") as seen by immunofluorescence (a--c, a'--c') and phase contrast (a"--c") microscopy. a-a" Cells cultivated 
for 4 h in the presence of 0.2 Ilg/ml AMD. Regions containing RNA polymerase I are reduced to small caps at the nucleolar periphery 
as revealed by immunofluorescence microscopy with S18 antibodies (a). Antibody 72B9 stains adjacent, much larger structures (a'). 
b-b" Injection of antibodies to RNA polymerase I into a cell (arrows) 1.5 h prior to fixation. The injected antibodies are concentrated 
in the nucleoli (b). Antibody 72B9 stains, in addition to the nucleoli, numerous nucleoplasmic entities in the injected cell (arrow) 
but not in adjacent control cells (b'). c--c" 4 h after microinjection of S18 antibodies. The distribution of the injected antibodies is 
shown in c (arrow). The nucleolar material recognized by antibody 72B9 is dispersed in numerous small entities throughout the nucleoplasm 
of the injected cell (arrow in c'). Note the different fluorescence pattern of the adjacent nontreated cells. Bar represents 50 Ilm 
redistribution of the nucleolar components did not result 
in the eventual disintegration of the nucleolar body 
(Figs. 1 a", 2 b"). Even after prolonged exposure of cells 
to AMD, segregated nucleoli remained as compact entities 
which, however, appeared gradually to lose the RNA poly-
merase I-dependent fluorescence, probably as a conse-
quence of the progressive release of the enzyme molecules 
from the rDNA template (see Scheer and Rose 1984). 
When antibodies to RNA polymerase I were injected 
into nuclei of interphase PtKz cells, a considerable propor-
tion accumulated in the nucleoli, as judged by immunof-
luorescence microscopy with FITC-labe1ed secondary anti-
bodies directed against the injected immunoglobulins 
(Figs. 1 b, c, 2c). This observation also demonstrated the 
accessibility of the nucleolar polymerases - which most lik-
ely represent the template-engaged form - to microinjected 
antibodies. At about 90 min after antibody injection, the 
first signs of nucleolar fragmentation became visible: anti-
body 72B9, which normally reacts with the DFC, stained 
an increasing number of small nucleoplasmic bodies, in ad-
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Fig.2a-c. Comparison of the effects of actinomycin D (AMD) (a-a", b-b") and RNA polymerase I (S18) antibodies microinjected 
into nuclei of PtKz cells (c--c") as demonstrated by immunofluorescence (a-c, a'-c') and phase contrast (a"-c") microscopy. In cells 
cultivated for 1 h (a-a") or 4 h (b-b") in the presence of AMD, RNA polymerase I-containing regions are reduced to small caps 
at the nucleolar periphery as revealed by immunofluorescence microscopy with S18 antibodies (a, b). Antibody RS1-105 stains, besides 
the cytoplasmic ribosomes, nucleoli of cells exposed for 1 h to AMD (a'). However, after 4 h of AMD treatment nucleoli are almost 
negative (b') . c-c" 4 h after microinjection of RNA polymerase I antibodies. The distribution of the injected antibodies is shown in 
c (the arrow denotes the injected cell). Antibody RS1-105 stains the nucleolus of both the injected (c', arrow) and the control cell 
(upper cell in c'). The cytoplasmic fluorescence is caused by the binding of the antibodies to ribosomes. Bar represents 50 Ilm 
dition to the residual nucleoli (Fig. 1 b'). The autoantibody 
Scl C produced the same pattern of immunofluorescence 
(not shown). At 4 h, the DFC fragmentation into small 
individual entities dispersed over the nucleoplasm had pro-
gressed (Fig. 1c'). Such extranucleolar bodies reacting with 
antibody 72B9 were never observed in interphase control 
cells (Fig. 1 b', c'). Nucleolar remnant structures, which were 
still visible by phase contrast optics (Fig. 1c"), were only 
weakly stained with antibody 72B9, suggestive of a consid-
erable loss of the DFC (Fig. 1c'). However, the same nuc-
leolar remnant structures retained a significant portion of 
ribosomal protein S1, as judged from the fluorescence inten-
sity observed with monoclonal antibody RS1-105 (Fig. 2c'). 
In contrast, the numerous nucleoplasmic bodies were not 
stained by the S1 antibodies (Fig. 2c'). 
Microinjection of RNA polymerase I antibodies into 
the nucleus of rat cells (RVF-SMC) gave essentially identi-
cal results (not shown). However, the smaller size and high-
er number of nucleoli in RVF-SMC cells made the interpre-
tation of the results more complicated. In addition, the nu-
cleoli of the rat cells did not show the same clear pattern 
of segregation after AMD treatment as the PtKz cells. 
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Fig. 3. a-a" Daughter cells derived from a PtK 2 mother cell which was injected 7 h before with RNA polymerase I (S18) antibodies 
(arrows) . The injected antibodies are concentrated in perinuclear aggregates in the two daughter cells (a). Antibody 72B9 stains numerous 
nucleoplasmic entities in the daughter cells whereas in the adjacent non-treated cell the fluorescence is confined to the nucleoli (a'). 
The corresponding phase contrast image is shown in a". Note the absence of nucleoli in the daughter cells in contrast to the adjacent 
control cell. b-b" Microinjection of control antibodies (Lo46F7) into the nuclei of PtK2 cells. After 4 h incubation the cells were 
fixed and processed for immunofluorescence microscopy (b, b'). The distribution of the injected antibodies is shown in b. Double-label 
immunofluorescence microscopy with the nucleolus-specific antibody Scl C (b'). The corresponding phase contrast image is shown 
in b". A non-injected cell is denoted by arrows (b', b"). Bar represents 50 !-lm 
Two types of control experiments are shown in Figure 3. 
When cells were cultured for prolonged periods of time 
after microinjection of RNA polymerase I antibodies, they 
proceeded through normal mitosis, indicating that the mi-
croinjection procedure did not interfere with this basic cel-
lular process (Fig. 3 a-a"). In the resulting daughter cells, 
the RNA polymerase I antibodies appeared to be largely 
excluded from the nuclei and were mostly recovered in cer-
tain cytoplasmic, perinuclear aggregates, perhaps IgG ag-
gregates (Fig. 3a). Reformation of nucleoli, however, was 
apparently prevented in these cells (Fig. 3 a"). These effects 
were indistinguishable from those observed after microin-
jection of the polymerase antibodies into mitotic PtK2 cells 
(Benavente et al. 1987). When probed with the monoclonal 
antibody 72B9, the daughter nuclei formed from the in-
jected mother cell were seen to contain numerous fluores-
cent dots, reminiscent of the prenucleolar bodies that nor-
mally occur exclusively during early telophase (Fig. 3 a' ; 
see also Benavente et al. 1987; cf. De la Torre and Gimenez-
Martin 1982). None of the nucleolar effects described was 
seen after injection of other, i.e. "irrelevant" antibodies 
(Fig. 3 b-b"). For example, PtK2 cells injected with the 
monoclonal antibody Lo46F7 which reacts with Xenopus 
laevis lamins Lm and L1v but not with mammalian lamins 
(Krohne and Benavente 1986) were indistinguishable from 
control cells: DFC antibodies (Scl C) exclusively stained 
the nucleoli in both microinjected and control cells 
(Fig.3b'). 
The electron microscopic appearance of nucleoli from 
PtK2 and RVF-SMC cells, before and after microinjection 
of antibodies to RNA polymerase I, is presented in Fig-
ures 4 and S. Nucleoli of PtK2 cells are of the compact 
type (Fig. 4a) whereas the rat cell nucleoli reveal a nucleo-
lonema organization (Fig. 4 b; the three main nucleolar 
components are indicated). By 4 h after microinjection of 
RNA polymerase I antibodies, nucleoli from both cell types 
appeared as relatively small and highly contrasted struc-
tures (Fig. Sa; for corresponding light microscopical ap-
pearance see also Fig. 1c"). Higher magnification revealed 
that the main body of these residual nucleoli consisted es-
sentially of granular material, with one or two FCs usually 
at the periphery (Fig. Sd, e), corresponding to the fluores-
cent cap structures containing the microinjected antibodies 
to RNA polymerase I (compare Figs. 1c and 2c with 
Fig. Sd, e). The third nucleolar structure, the DFC, was 
either absent or considerably reduced in such residual nucle-
oli (Fig. Sd, e). On the other hand, numerous round ish ag-
gregates composed of tightly packed fibrillar material could 
be recognized, which were scattered throughout the nuclear 
interior and did not show any structural connections to 
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Fig. 4a, b. Electron micrographs of nucleoli of untreated rat kan-
garoo (PtK 2 , a) and rat (RYF-SMC, b) cells. The three main nuc-
leolar components are clearly visible, i.e. FC fibrillar center, DFC 
dense fibrillar component and GC granular component. Bars repre-
sent 1 Ilm 
the nucleolar remnants (Fig. 5a). These spheroidal bodies 
resembled in their texture the DFC of normal nucleoli 
(Fig. 5b). In fact, antibody 72B9, which reacts specifically 
with DFC, decorated these nucleoplasmic bodies as demon-
strated by immunogold electron microscopy (Fig. 5c; for 
immunofluorescence see Fig. lc'). 
Discussion 
In the present study we have examined the ability of anti-
bodies directed against RNA polymerase I to induce struc-
tural changes in nucleoli when directly microinjected into 
the nuclei of interphase cells. The two kinds of antibodies 
used, i.e. experimentally raised antibodies to rat RNA poly-
merase I and human RNA polymerase I auto antibodies 
have previously been shown to neutralize RNA polymerase 
I activity in vitro and to reduce or even suppress rRNA 
synthesis upon rnicroinjection into cultured mammalian 
cells and Xenopus oocytes (Rose et al. 1981 ; Mercer et al. 
1984; Schlegel et al. 1985 ; Reimer et al. 1987 a). In addition, 
recent microinjection experiments have demonstrated that 
these antibodies also inhibit the postmitotic reformation 
of nucleoli when microinjected into mitotic PtK2 cells (Ben-
avente et al. 1987). In view of the general experience that 
almost any agent interfering with the complex process of 
ribosome biogenesis may cause one or another structural 
change in interphase nucleoli (for references see Bernhard 
1971; Simard et al. 1974 ; Smetana and Busch 1974; Daskal 
1979; Bouteille et al. 1982 ; Hadjiolov 1985) it is not surpris-
ing that nuclear microinjection of RNA polymerase I anti-
bodies into living interphase cells alters the nucleolar archi-
tecture. However, our results with RNA polymerase I anti-
bodies are particularly novel and significant as this experi-
mental approach allowed the selective inhibition of tran-
scription of the rRNA genes with a minimum of side effects 
on other genes and other proteins. Remarkably, the pattern 
of structural alterations of the nucleolus induced by the 
microinjected antibodies is different from that produced 
by most inhibitory drugs. 
The most striking nucleolar change observed after inhi-
bition of rDNA transcription by microinjected antibodies 
to RNA polymerase I was a progressive loss ofDFC materi-
al from the nucleoli, with the concomitant occurrence of 
small, purely fibrillar extranucleolar bodies scattered 
throughout the nucleoplasm. These morphological changes 
were first detectable at about 1- 2 h after antibody injection. 
Based on 3H-uridine incorporation studies, it has been 
shown that inhibition ofnucleolar RNA synthesis by micro-
injection of RNA polymerase I antibodies reaches a maxi-
mum at this time point and is subsequently maintained 
for several hours (Mercer et al. 1984). By morphological 
and immunological criteria the experimentally induced ex-
tranucleolar bodies resembled fragments of the DFC of nor-
mal nucleoli as they contained the protein fibrillarin which 
is a specific marker of this nucleolar structure (Ochs et al. 
1985; Reimer et al. 1987b). The nucleoplasmic bodies pres-
ent in microinjected Xenopus A6 cells contained, in addi-
tion, another specific DFC protein with an Mr of 180,000 
(data not shown; cf. also Schmidt-Zachmann et al. 1984). 
In contrast, precursor particles to the small ribosomal sub-
unit as well as RNA polymerase I molecules could not be 
detected in these bodies. They apparently remained bound 
to the nucleolar remnant structures which consisted almost 
purely of GC with FCs still attached. 
At first sight it seems puzzling that the morphological 
changes in the nucleoli induced by nuclear injection of RNA 
polymerase I antibodies are clearly different from the dis-
tinctive segregation phenomenon caused by a variety of 
DNA-binding drugs such as AMD (e.g. Bernhard 1971; 
Simard et al. 1974) although both treatments interfere with 
pre-rRNA synthesis. However, it has to be emphasized that 
reduction of pre-rRNA synthesis alone does not necessarily 
lead to nucleolar segregation, as illustrated by a variety 
of drugs and treatments which efficiently block nucleolar 
RNA synthesis but do not induce nucleolar segregation (for 
refs. see Bernhard 1971; Simard et al. 1974; Hadjiolov 
1985). In addition, nucleolar segregation by AMD can be 
prevented by combination with other drugs (see Monneron 
1971), again indicating that the segregation phenomenon 
is not a simple response to inhibition ofrDNA transcription 
but is the result of more complex processes (for discussion 
see Hadjiolov 1985). On the other hand, the morphological 
changes described in the present study are also different 
from other typical drug-induced nucleolar lesions such as 
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Fig.5a--e. Effects of human (a, b, d) and rabbit (c, e) RNA polymerase I antibodies 4 h after intranuclear injection into PtK2 (a, 
b, d) and RYF-SMC (c, e) cells as shown by electron microscopy. Residual nucleoli appear as compact structures (N in a). In addition, 
numerous smaller spherical bodies of high contrast are present in the nucleoplasm (some of them are denoted by arrowheads in a). 
They consist primarily of fibrillar material (b) and contain the antigen recognized by monoclonal antibody 72B9 as shown by the 
distribution of the 5 nm gold particles (c). d, e The residual nucleolar structures are composed primarily of the granular component 
(GC) with fibrillar centers (FC) at their periphery. The dense fibrillar component is almost absent from these structures. Bars represent 
2 !lm (a) and 0.5 !lm (b--e) 
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nucleolar degranulation and fragmentation (for review see 
Simard et al. 1974) and resemble only the "100% granular 
nucleoli" described in rat hepatocytes after treatment with 
both AMD and thioacetamide (Narayan et al. 1966). 
Most strikingly, the gradual disappearance of the DFC 
from the nucleoli observed after RNA polymerase I anti-
body injection resembles early stages in their natural nuc-
leolar breakdown during mitotic prophase. As shown by 
Goessens and Lepoint (1974 ; reviewed by Goessens 1984) 
the DFC disappears first in prophase, leaving behind a nu-
cleolus of pure GC with attached FCCs). It is, therefore, 
tempting to speculate that the experimentally induced dis-
appearance of the DFC by the microinjected antibodies 
mimics to some extent the naturally occurring primary steps 
of nucleolar disintegration at the beginning of mitosis in 
that both events are initiated by reduced or blocked activity 
of RNA polymerase I. In addition, the nucleoplasmic bod-
ies described in the present study resemble by morphologi-
cal and immunological criteria the prenucleolar bodies 
which appear toward the end of mitosis during the early 
stages of nucleologenesis (see Fig. 3 a-a" ; for the behavior 
of the DFC during mitosis see Schmidt-Zachmann et al. 
1984; Reimer et al. 1987c). These naturally occurring pre-
nucleolar bodies arise in the absence of pre-rRNA synthesis 
but their assembly into the nucleolar body requires the ac-
tivity of the rRNA genes (for a detailed discussion see Bena-
vente et al. 1987). 
Taken together, our findings lend further support to 
our previous suggestion that the DFC represents a genuine 
component of the nucleolus and is not a transient structure 
formed by the superposition of rDNA transcription units 
and primary transcriptional products (Schmidt-Zachmann 
et al. 1984; Benavente et al. 1987). Furthermore our data 
show that the nucleolar location and the integration of the 
DFC into nucleoli is critically dependent on ongoing tran-
scription of the rRNA genes. We therefore propose, in con-
trast to the currently prevailing concept of DFC structure 
and function , that the nascent transcripts of the rRNA 
genes serve as specific nucleation sites for DFC assembly. 
Based on the present data as well as our previous study 
(Benavente et al. 1987) we also conclude that microinjection 
of antibodies directed against nucleolar constituents into 
living cells combined with double-label immunocytochem-
istry is a valuable experimental approach in studies of the 
relationship between nucleolar structure and function. We 
hope that the use of antibodies as highly specific tools will 
lead to a better understanding of the functional organiza-
tion of the nucleolus and the interplay between specific 
structures and biochemical reactions. 
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